Iliopsoas Nerve Block and Femoral Nerve Block in Hip Fracture Surgeries

NCT06852378 | Recruiting

• 1 other identifier: FMASU MD38/2025
• Study Type: observational
• Target: 80
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to compare iliopsoas nerve Block (IPB) to femoral nerve block (FNB) regarding pain control, patient satisfaction, and early ambulation in patients undergoing hip fracture surgeries

Conditions

Iliopsoas Nerve Block; Femoral Nerve Block; Hip Fracture Surgeries

Outcome Measures

Primary Outcomes (1)

• Degree of pain

  Each patient will be instructed about postoperative pain assessment with the numeric rating scale (NRS) score. NRS (0 represents "no pain" while 10 represents "the worst pain imaginable"). NRS will be assessed upon arrival at the post-anesthesia care unit (PACU) and at 2, 4, 6,12, 24 post-surgery.

  24 hours postoperatively

Secondary Outcomes (5)

• Total opioids consumption

  24 hours postoperatively

• Assessment of quadriceps strength

  24 hours postoperatively

• Time of ambulation

  24 hours postoperatively

• Patients' satisfaction

  24 hours postoperatively

• Incidence of complications

  24 hours postoperatively

Study Arms (2)

Iliopsoas nerve block group

Patients will receive an Iliopsoas nerve block using 10 ml of bupivacaine 0.5%.

Drug: Iliopsoas nerve block

Femoral nerve block group

Patients will receive femoral nerve block using 10 ml of bupivacaine 0.5%.

Drug: Femoral nerve block

Interventions

Iliopsoas nerve block DRUG

Patients will receive an Iliopsoas nerve block using 10 ml of bupivacaine 0.5%.

Also known as: Bupivacaine 0.5%

Iliopsoas nerve block group

Femoral nerve block DRUG

Patients will receive femoral nerve block using 10 ml of bupivacaine 0.5%.

Also known as: Bupivacaine 0.5%

Femoral nerve block group

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

This prospective, single-blind cohort study will be conducted on 80 patients scheduled for elective surgical correction of hip fracture after obtaining approval from the Research Ethical Committee of Ain Shams University. It will be conducted in the assembled operation rooms in Ain Shams University Hospitals.

You may qualify if:

• Age from 18 to 65 years.
• Both sexes.
• American Society of Anesthesiologists (ASA) physical status I and II.
• Patients who are scheduled for elective surgical correction of hip fracture either through open fracture internal fixation (ORIF), partial hip arthroplasty or total hip arthroplasty.

You may not qualify if:

• Refusal to participate.
• Coagulopathy.
• Patients with a history of drug allergies to study drugs.
• Inability to cooperate.

Sponsors & Collaborators

• Ain Shams University: lead

Study Sites (1)

Ain Shams University

Cairo, 11591, Egypt

RECRUITING

Central Study Contacts

Hazem K Saeed, Master

CONTACT

00201016056123; hazem.khaled@med.asu.edu.eg

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Lecturer of Anesthesia, Intensive Care and Pain Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Study Record Dates

• First Submitted: February 25, 2025
• First Posted: February 28, 2025
• Study Start: March 1, 2025
• Primary Completion: February 1, 2026
• Study Completion: February 1, 2026
• Last Updated: March 4, 2025

Record last verified: 2025-03

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL
• Time Frame: After the end of study for one year.
• Access Criteria: The data will be available upon a reasonable request from the corresponding author.

Locations

EG (1)